# Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

> **NCT02870907** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Institut Curie** · enrollment: 195 (estimated)

## Conditions studied

- Retinoblastoma

## Interventions

- **OTHER:** Observation
- **DRUG:** Etoposide
- **DRUG:** Vincristine
- **RADIATION:** Orbital irradiation
- **DRUG:** Carboplatin
- **DRUG:** Vincristine
- **DRUG:** Cyclophosphamide
- **DRUG:** Carboplatin
- **DRUG:** Etoposide
- **DRUG:** Carboplatin
- **DRUG:** Thiotepa
- **DRUG:** Vincristine
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** Cytapheresis
- **DRUG:** Carboplatin
- **DRUG:** Etoposide
- **DRUG:** Thiotepa
- **PROCEDURE:** Peripheral bood stem cell transplantation

## Key facts

- **NCT ID:** NCT02870907
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2010-03-18
- **Primary completion:** 2031-03-01
- **Final completion:** 2031-03-01
- **Target enrollment:** 195 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02870907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02870907, "Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02870907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*